FIGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FIGR is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has constructive near-term business momentum and some bullish analyst support, but the recent bearish research note, stretched options activity, and an earnings event in just a few days make the setup less attractive for an impatient buyer. If you need to act now, I would not start a large position here; hold off for the earnings reaction or a better entry.
The technical picture is mildly bullish but not strong enough for an aggressive buy. MACD histogram is positive and expanding, which supports upward momentum. RSI_6 at 65.7 is near the upper range but not overbought. Moving averages are converging, suggesting the trend is not yet fully established. Price at 37.4 is just below R1 resistance at 38.143 and above the pivot at 35.213, so the stock is testing resistance rather than breaking out decisively. The short-term pattern estimate suggests possible near-term weakness over the next week, even though the one-month outlook is positive.
April consumer loan marketplace volume rose to $1.338B, up 12% from March and 108% year over year. Borrower demand also increased 5% month over month, showing healthy platform activity. Goldman Sachs recently raised its price target to $44 and kept a Buy rating, citing stronger March and Q1 preliminary operating data, improving origination partner growth, and seasonally improving HELOC demand. The next earnings date is 2026-05-11 after hours, which could act as a catalyst if results confirm the volume trend.
Morpheus Research published a sharply bearish note on 2026-04-16, arguing the stock is overpromoted and should be shorted. Available lender supply fell 6% in April, and YLDS circulation declined 12% month over month, showing mixed platform breadth. Shares are approaching resistance ahead of earnings, and the short-term modeled trend points to a possible weekly pullback. No notable politician, insider, hedge fund, or congress trading support was reported recently.
Latest quarter shown is 2025/Q4. Revenue was $159.9M, net income was $23.0M, and EPS was $0.09, with EPS up 12.5% year over year. Revenue was reported as flat year over year in the snapshot, so the quarterly financial data does not show strong acceleration on its own. The better growth signal comes from operating data, where April marketplace volume and year-over-year origination growth were very strong.
Analyst sentiment is mixed but still leaning positive. Goldman Sachs remains Buy and raised its target to $44 from $42 on 2026-04-06. Bernstein kept Outperform but cut its target to $67 from $72 on 2026-03-30. Mizuho lowered its target twice, to $45 from $55 and earlier to $55 from $64, while keeping Outperform. Goldman also cut its target earlier to $39 from $44 before later raising it again. The wall street pro view is that Figure has strong long-term growth, expanding partnerships, and improving HELOC volumes. The con view is centered on valuation, lower market multiples, and the recent bearish critique that Figure is more of a HELOC lender than a true blockchain disruptor. Overall, analysts are constructive, but conviction is not uniformly strong.
